Eversense Implantable CGM: How It Works

What Is the Eversense Implantable CGM?

The Eversense CGM system by Senseonics represents a major leap forward in continuous glucose monitoring technology. Unlike traditional CGM sensors that sit on the surface of the skin and require replacement every 7–14 days, the Eversense sensor is implanted just beneath the skin and can last up to 365 days in its latest version (Eversense E3). For people with diabetes who are tired of frequent sensor changes, this long-lasting option is a game-changer.

How the Eversense Sensor Is Implanted

The Eversense sensor is a small, cylindrical device about the size of a small pill. A trained healthcare provider inserts it just under the skin of the upper arm during a simple, in-office procedure. Local anesthesia is used to numb the area, making the process minimally uncomfortable. Once implanted, the sensor begins working continuously to measure glucose levels in the interstitial fluid surrounding your cells.

When it's time for a replacement — typically after 180 days for the E3 in a single-arm cycle or up to 365 days with a dual-arm approach — a clinician removes the old sensor and inserts a new one. Many patients find this far more convenient than dealing with weekly sensor changes at home.

The Science Behind the Technology

The Eversense sensor uses fluorescence-based technology to measure glucose. This is a fundamentally different approach from the electrochemical method used by most wearable CGMs like Dexcom or Libre.

Here's how it works:

• The implanted sensor contains a glucose-sensitive fluorescent chemical called a fluorophore.
• When glucose molecules in the interstitial fluid bind to this chemical, it changes the intensity of the fluorescence emitted.
• A light-emitting component in the sensor measures these fluorescence changes.
• This data is then transmitted to the external smart transmitter worn over the implant site.

The smart transmitter converts the fluorescence signals into glucose readings and sends them to a compatible smartphone app every five minutes. The transmitter is removable and rechargeable, meaning you can take it off for swimming, showering, or contact sports without interrupting the implanted sensor itself.

On-Body Vibration Alerts

One standout feature of the Eversense system is its on-body vibration alerts. Because the transmitter sits directly on the skin over the implant, it can vibrate against the body when glucose levels go too high or too low — even if your phone is across the room. This tactile feedback provides an extra layer of safety that many users find invaluable, especially overnight.

Accuracy and Calibration

The Eversense E3 has demonstrated strong accuracy with a Mean Absolute Relative Difference (MARD) of around 8.5%, which is competitive with leading wearable CGMs. The system typically requires one fingerstick calibration twice daily, though this is a trade-off many users accept for the benefit of a long-lasting implant.

Who Is Eversense Right For?

The Eversense CGM is FDA-approved for adults with diabetes aged 18 and over. It may be an especially good fit for people who:

• Experience skin irritation or adhesive allergies from traditional CGM patches
• Want to avoid frequent sensor changes
• Lead active lifestyles that make wearable sensors difficult to maintain
• Prefer discreet, long-term glucose monitoring

For those exploring advanced CGM options, resources available at mdsdiabetes.com can help you compare systems and find the right fit for your lifestyle and management goals.

Final Thoughts

The Eversense implantable CGM offers a compelling alternative to traditional wearable sensors. With its fluorescence-based technology, long sensor life, on-body vibration alerts, and removable transmitter, it addresses several common pain points for CGM users. As implantable technology continues to evolve, Eversense stands at the forefront of what the future of glucose monitoring may look like.